Susceptibility to BK polyomavirus-associated hemorrhagic cystitis in children undergoing allogeneic transplant. Haematologica: the hematology journal. 2025; 110:527-531.
.2025; 31:s515-s516.
. Bkpyv Replication Kinetics and Association with Hemorrhagic Cystitis in Pediatric HSCT Recipients. Transplantation and Cellular Therapy.Clinical spectrum of primary hemophagocytic lymphohistiocytosis: experience of reference centers in Central and Southeast Anatolia. Annals of Hematology. 2025; 104:123-130.
.2025; 31:s39-s41.
. Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome - Impact of Age, Donor, and Infection: A Pidtc Report. Transplantation and Cellular Therapy.2025; 31:s148-s149.
. A 10-Year History of Graft Failure in Pediatric Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy.2025; 31:s149-s150.
. Frequent Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Brief Transpire Report. Transplantation and Cellular Therapy.2025; 31:s147.
. Male Gender and Underlying Diagnosis Predisposes to Increased HLA Antibody Burden in Children before Allogeneic Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy.Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season. The Journal of Infectious Diseases. 2025; 231:e123-e131.
.2025; 31:s60-s61.
. Impact of Graft Versus Host Disease Following Allogeneic Hematopoietic Cell Transplantation on Leukemia Free Survival in Hematologic Malignancies: A CIBMTR Analysis. Transplantation and Cellular Therapy.2025; 31:s375-s376.
. Beyond Survival: Assessing Renal and Cardiovascular Health in Fanconi Anemia Adolescents and Young Adults Post-Stem Cell Transplant. Transplantation and Cellular Therapy.2025; 31:s364-s365.
. Real-World Assessment of Patient Adherence to the Late Effects Screening Recommendations Among Hematopoietic Cell Transplantation Survivors. Transplantation and Cellular Therapy.The Fas-mediated apoptosis assay: From concept to clinical application. Journal of Immunological Methods. 2025; 537:113812.
.2025; 12:ofae631.198.
. 633. Incidence and Outcomes of Pediatric Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients Under Surveillance and Not Under Surveillance for Human Adenovirus (HAdV) in the Post-HCT Period. Open Forum Infectious Diseases.2025; 31:s145-s146.
. Differential Filtration of Macromolecules: A Novel Indicator of Mortality Risk in Pediatric HSCT Patients. Transplantation and Cellular Therapy.Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature. Science immunology. 2025; 10:eadq1697.
.2025; 53.
. 1187: ECMO IN PEDIATRIC ONCOLOGIC AND HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: A COMPARATIVE ANALYSIS. Critical Care Medicine.Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study. Arthritis and Rheumatology. 2025; 77:226-238.
.Protein-Protein Interactions of Odorant and G Protein-Coupled Receptors: A BRET Analysis Approach. Methods in molecular biology (Clifton, N.J.). 2025; 2915:161-168.
.Yellow Fluorescent Protein Quenching Assay for Analyzing Odorant Receptor Activity. Methods in molecular biology (Clifton, N.J.). 2025; 2915:169-177.
.Oxidative Stress Early After Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2025; 31:135.e1-135.e10.
.Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes. Transplantation and Cellular Therapy. 2025; 31:123-134.
.2025; 31:s2-s3.
. Gene Therapy with Reduced-Intensity Conditioning for Sickle Cell Disease. Transplantation and Cellular Therapy.Hydroxyurea for Children and Adults with Hemoglobin SC Disease. 2025; 4:EVIDoa2400402.
.2025; 31:s221-s222.
. Outcome Analysis Post Virus-Specific T Cell Therapy for the Treatment of Adenoviremia in Immunocompromised Pediatric Patients. Transplantation and Cellular Therapy.Relevance of Recent Thymic Emigrants Following Allogeneic Hematopoietic Cell Transplantation for Pediatric Patients with Inborn Errors of Immunity. Transplantation and Cellular Therapy. 2025; 31:265.e1-265.e12.
.Reconstitution of Norovirus-Specific T-Cell Responses Following Hematopoietic Stem Cell Transplantation in Patients With Inborn Errors of Immunity and Chronic Norovirus Infection. The Journal of Infectious Diseases. 2025; 231:773-783.
.2025; 31:s343-s344.
. Understanding Diversity: An ASTCT-NMDP Access Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Nonphysician Workforce. Transplantation and Cellular Therapy.2025; 31:s361.
. Physician Workforce Diversity in the Hematopoietic Cell Transplant and Cellular Therapy Ecosystem: An ASTCT-NMDP Access Initiative Survey. Transplantation and Cellular Therapy.2025; 31:s153.
. Managing Diffuse Alveolar Hemorrhage in Pediatric HSCT with Inhaled and Intrabronchial Therapy: A Case Series of Targeted Hemostatic Intervention. Transplantation and Cellular Therapy.2025; 31:s282.
. Incidence of Transplant-Associated Thrombotic Microangiopathy (TA-TMA) Is Not Lowered By Reduction of Acute GvHD (aGvHD) in Patients Receiving Post-Transplant Cyclophosphamide (PTCy) GvHD Prophylaxis: A Report from the MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium. Transplantation and Cellular Therapy.2025; 31:s529-s530.
. Establishing the Engraft Multi-Center Tri-Use Registry. Transplantation and Cellular Therapy.2025; 31:s98.
. Longitudinal Outcomes of Fertility Potential in Female Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplant Survivors. Transplantation and Cellular Therapy.2025; 31:s93-s94.
. Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study. Transplantation and Cellular Therapy.Chronic Graft-Versus-Host Disease Adversely Impacts School Performance in Children and Young Adults. Transplantation and Cellular Therapy. 2025; 31:99.e1-99.e11.
.Stretchable Heat Transfer Eco-Materials: Mesogen Grafted NR-Based Nanocomposites with High Thermal Conductivity and Low Dielectric Constant. Small. 2025; 21:e2406066.
.2025; 31:s305-s306.
. Single Center Experience of Belumosudil in Children < 12 Years, Adolescents and Young Adults. Transplantation and Cellular Therapy.2025; 2:100055.
. Kinetics of DNases after hematopoietic stem cell transplant.2025; 12:1550365.
. Translating biomarker insights into practice: a path forward in TA-TMA management. Frontiers in Medicine.Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part III. Long-Term Impact of Chronic Graft-versus-Host Disease on Endocrinologic, Cardiovascular, and Metabolic Outcomes in Survivors of Pediatric Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 2025; 31:297.e1-297.e15.
.2025; 1.
. Addition of Thiotepa to Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Reduces Secondary Graft Failure in Allogeneic HSCT for Inborn Errors of Immunity.2025; 31:s153-s154.
. Pravastatin Prophylaxis Is Safe and Feasible in Children and Young Adults Undergoing Allogeneic HSCT: A Prospective, Single Arm Cohort Study. Transplantation and Cellular Therapy.2025; 31:s311-s312.
. Beyond Graft-Vs-Host Disease: The Role of Cellular Senescence in Persistent Liver Injury in Fanconi Anemia after HSCT. Transplantation and Cellular Therapy.2025; 31:s137.
. The Tell-Tale Heart: A Cytokine Storm Story of Pericardial Effusions after HSCT. Transplantation and Cellular Therapy.2025; 31:s308-s309.
. Transcriptomic Alterations and Clonal Evolution Identifies a Pre-Emptive Indication for Hematopoietic Stem Cell Transplant in Fanconi Anemia. Transplantation and Cellular Therapy.2025; 31:s546.
. Higher Dose Intravenous Posaconazole Is Safe and Necessary for Achievement of Therapeutic Targets and Prevention of Infections in Pediatric Hematopoietic Stem Cell Transplant Patients. Transplantation and Cellular Therapy.2025; 31:s314.
. Urine Kidney Injury Biomarkers Predict TMA Risk in Pediatric HSCT Recipients. Transplantation and Cellular Therapy.2025; 31:s313-s314.
. Supar Is a Novel and Powerful Biomarker of TMA and Kidney Injury after HSCT. Transplantation and Cellular Therapy.2025; 31:s509-s510.
. Effect of Clinically Relevant Immunosuppressants on Viral Specific T-Cell (VST) in Vitro Function. Transplantation and Cellular Therapy.PBAE-PEG-based lipid nanoparticles for lung cell-specific gene delivery. Molecular Therapy. 2025; 33:1154-1165.
.Clinical, Immunologic, and Genetic Characteristics in Patients With Syndrome of Undifferentiated Recurrent Fevers. Arthritis and Rheumatology. 2025; 77:596-605.
.2025; 31:s501.
. Establishing a Quality Improvement Education Platform in the Engraft Learning Network. Transplantation and Cellular Therapy.2025; 31:s145.
. The HCT Protein Shake: Moderate and Severe Proteinuria Are Specific to TA-TMA. Transplantation and Cellular Therapy.2025; 12:ofae631.310.
. P-103. Adenoviremia Clearance Following Treatment with Intravenous (IV) Brincidofovir (BCV) in Immunocompromised Patients is Associated with Positive Clinical Disease Response: Preliminary Outcomes from the ATHENA Phase IIa Study. Open Forum Infectious Diseases.2025; 1.
. Precision Alemtuzumab Dosing Results in Day 0 Target Range Achievement in 80% of IEI Patients and Minimizes Risks of GVHD, Clinically Significant Mixed Chimerism, and Secondary Graft Failure.Diagnostic testing for hemophagocytic lymphohistiocytosis. Journal of Immunological Methods. 2025; 537:113816.
.Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study. The Lancet. Rheumatology. 2025; 7:e243-e251.
.2025; 31:s513-s514.
. The First Prospective Screening Study of BK Polyomavirus (BKPyV) Hemorrhagic Cystitis after HSCT. Transplantation and Cellular Therapy.2025; 31:s317-s318.
. Defining and Assessing Poor Graft Function after Allogeneic HSCT in Children and Young Adults. Transplantation and Cellular Therapy.2025; 31:s514-s515.
. Plasma LILRA6 Levels Influence BK Polyomavirus Cystitis after HSCT. Transplantation and Cellular Therapy.Phase 1 study of quercetin, a natural antioxidant for children and young adults with Fanconi anemia. Blood Advances. 2025; 9:1927-1939.
.Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT. Bone Marrow Transplantation. 2025; 60:406-411.
.2025; 31:s451.
. Nurse Driven Central Line Rounding Utilized to Improve Bone Marrow Transplant Patient Outcomes: An Update. Transplantation and Cellular Therapy.2025; 31:s542-s543.
. Unraveling the Challenges of Non-Responders to the Eculizumab Treatment with High-Risk Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA). Transplantation and Cellular Therapy.Receipt of Fluoroquinolone Prophylaxis is not Associated With Development of Vancomycin-Resistant Enterococcus Colonization During Pediatric Hematopoietic Cell Transplantation. Journal of the Pediatric Infectious Diseases Society. 2025; 14:piaf010.
.Clinical Use of ZSCAN4 for Telomere Elongation in Hematopoietic Stem Cells. 2025; 4:EVIDoa2400252.
.G-CSF resistance of ELANE-mutant neutropenia depends on SERF1-containing truncated-neutrophil elastase aggregates. The Journal of Clinical Investigation. 2025; 135:e177342.
.Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH). Orphanet Journal of Rare Diseases. 2025; 20:200.
.2025; 31:s26-s27.
. Soluble Fms-like Tyrosine Kinase-1 (sFlt-1) As a Clinical Biomarker for Individual Susceptibility to Post-Transplant Complications: A Report from the MIDAS Consortium. Transplantation and Cellular Therapy.Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial. Blood Advances. 2025; 9:1791-1800.
.2025; 44:s355.
. (750) Single Cell Technology Shines LIGHT on Acute Lung Allograft Dysfunction. The Journal of Heart and Lung Transplantation.Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions Trial. Acta Haematologica. 2025; 148:208-219.
.2025; 31:s342.
. Perception and Reality of Racial and Ethnic Workforce Diversity in the U.S HCT/CT Workforce: Results from the ASTCT-NMDP Access Initiative Survey. Transplantation and Cellular Therapy.2025; 31:s25-s26.
. Pre-Transplant Complement Activation and Transplant-Associated Thrombotic Microangiopathy (TA-TMA) across Diagnostic Groups. Transplantation and Cellular Therapy.Long-term kidney outcomes in survivors of Wilms tumor: a single-center retrospective cohort study. Pediatric Nephrology. 2025; 40:1603-1611.
.2025; 31:s133.
. TA-TMA Evolution and Individual Susceptibility at the Proteome Level. Transplantation and Cellular Therapy.2025; 31:s535-s536.
. Variation in Central Venous Catheter Practices and Complications after Stem Cell Transplant: A Multi-Center Survey of the Engraft Learning Network. Transplantation and Cellular Therapy.2025; 31:s133-s134.
. Pre-Transplant Endothelial Activation May Increase Individual Susceptibility Transplant-Associated Thrombotic Microangiopathy in Adults: A Report from the MIDAS Consortium. Transplantation and Cellular Therapy.2025; 31:s489.
. Scrubbing Olympics: Next Steps. Transplantation and Cellular Therapy.2025; 31:s167.
. The Novel Role of Pilra in BK Polyomavirus Cystitis after HSCT. Transplantation and Cellular Therapy.2025; 31:s146.
. Inbody Assessments Reveal Important Changes in Body Mass Composition during HCT. Transplantation and Cellular Therapy.The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities. Transplantation and Cellular Therapy. 2025; 31:109.e1-109.e13.
.2025; 31:s92-s93.
. The Role of Second Hematopoietic Cell Transplantation (HCT2) in Patients with Severe Combined Immunodeficiency (SCID): A Report from the Primary Immune Deficiency Treatment Consortium (PIDTC). Transplantation and Cellular Therapy.Hemostatic derangements associated with cardiopulmonary bypass predict outcomes in pediatric patients undergoing corrective heart surgery. Journal of Thrombosis and Haemostasis. 2025; 23:492-503.
.2025; 31:s149.
. Pre-HCT Creatinine and Early Post-HCT Changes in Creatinine and Blood Pressure Associate with Severe Transplant Associated Thrombotic Microangiopathy (TA-TMA): A Report from the MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium. Transplantation and Cellular Therapy.Splicing regulatory dynamics for precision analysis and treatment of heterogeneous leukemias. Science Translational Medicine. 2025; 17:eadr1471.
.2025; 31:s316-s317.
. Characterizing the Gut Microbiome in Pediatric Patients Undergoing Hematopoietic Cell Transplant for a Non-Malignant Diagnosis. Transplantation and Cellular Therapy.2025; 31:s355.
. Influence of the Incorporation of a Muslim Chaplain on Medical Decision-Making in a Pediatric Hematopoietic Cell Transplant Program. Transplantation and Cellular Therapy.Regulated GATA1 expression as a universal gene therapy for Diamond-Blackfan anemia. Cell Stem Cell. 2025; 32:38-52.e6.
.2025; 31:s307-s308.
. Single Cell Rnaseq Identifies Novel Graft Rejection Mechanisms and Resurgence of Recipient NK and T-Cells. Transplantation and Cellular Therapy.